News

With the festive holiday season upon us, many tend to indulge in the various rich, festive treats on offer. December is a joyful time; it is also a time to relax and treat yourself; however, the festive eating can take...

Rbeck Healthtech Private completes registration for the NObreath® FeNO device, helping to improve asthma care across the region. Bedfont® Scientific Limited, world leaders in breath analysis, with over 48 years of experience in designing and manufacturing medical breath analysis devices,...

Part 3: Asthma treatment in 2024: Navigating the new recommendations for every age After exploring diagnostic changes and the pivotal role of Fractional exhaled Nitric Oxide (FeNO) in asthma care, part 3 of our series shifts the focus to treatment...

Part 2: Why FeNO first? Spotlight on testing & special cases In Part 1, we explored the redefined approach to asthma diagnosis under the new NICE/BTS/SIGN guidelines. In Part 2, we dive deeper into the role of Fractional exhaled Nitric...

Part 1: Understanding the changes – Asthma diagnosis & first steps in the new guidelines In light of the recent update to the National Institute of Care Excellence (NICE) guidelines for asthma care and management, Bedfont® Scientific Limited sponsored an...